Your session is about to expire
← Back to Search
Remaking Recess for Autism (RR Trial)
N/A
Waitlist Available
Research Sponsored by Health Resources and Services Administration (HRSA)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Must not have
Children under the age of 5 or over 12
Parent/Caregiver not willing to participate
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12 months, and 18 months
Awards & highlights
No Placebo-Only Group
Summary
This trial tests Remaking Recess, a program that helps children with autism or developmental disorders engage socially during school recess. It targets children aged 5-12 and involves training school staff to support these children in social interactions through structured play activities. Remaking Recess is designed to improve peer engagement for children with autism spectrum disorder (ASD) during recess.
Who is the study for?
This trial is for children aged 5-12 with Autism Spectrum Disorder (ASD) or other neurodevelopmental disorders who spend most of their day in general education and come from under-resourced families. Eligible schools are those receiving Title I funding or located in rural areas, and the family income must be below 250% of federal poverty guidelines. School personnel involved with these children can also participate.
What is being tested?
The AIR-B4 study tests the 'Remaking Recess' intervention aimed at improving social engagement during recess for kids with ASD. It involves training school staff to implement play-based activities over approximately five hours throughout the school year, assessing effectiveness when combined with an implementation strategy called UNITED.
What are the potential side effects?
Since this is a behavioral intervention involving professional development and coaching without medical treatments, there are no direct physical side effects expected from participating in Remaking Recess.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
My child is either under 5 years old or over 12.
Select...
My parent or caregiver is not willing to participate.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 12 months, and 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12 months, and 18 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Stages of Implementation Completion (SIC)
Secondary study objectives
Clinical Global Rating (CGI)
School Implementation Climate Scale
Social Network Survey- participants of survey will name key personnel that can be participants of the UNITED team for this intervention
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: UNITEDExperimental Treatment1 Intervention
UNITED is premised on the idea that successful implementation in organizations like schools and early intervention systems requires a team-based approach, in which the team is thoughtfully assembled, develops a plan for implementation, assigns roles and responsibilities, and carefully tracks and supports implementation and sustainment in all its stages within a few meetings and ongoing coaching from the research staff.
Group II: Implementation as Usual (IAU)Active Control1 Intervention
The organizations will implement RR as usual. The research team will be available to provide support on the RR intervention as needed.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Play-based interventions, such as the Remaking Recess program, work by creating structured opportunities for children with Autism Spectrum Disorder (ASD) to engage in social interactions within natural settings like school recess. These interventions typically involve training school personnel to facilitate and encourage peer interactions, thereby improving social skills and peer engagement.
The mechanisms of action include modeling appropriate social behaviors, providing prompts and reinforcement, and creating a supportive environment that reduces anxiety and promotes positive social experiences. This approach is crucial for ASD patients as it helps them develop essential social skills, enhances their ability to form meaningful relationships, and improves their overall quality of life.
Additionally, early and intensive interventions that are individualized and involve family participation are associated with better outcomes, making these strategies vital for the developmental progress of children with ASD.
A pilot tennis program for training fitness and social behaviors in individuals with autism spectrum disorder.Could You Give Me the Blue Brick? LEGO<sup>®</sup>-Based Therapy as a Social Development Program for Children with Autism Spectrum Disorder: A Systematic Review.A Multisite Randomized Controlled Two-Phase Trial of the Early Start Denver Model Compared to Treatment as Usual.
A pilot tennis program for training fitness and social behaviors in individuals with autism spectrum disorder.Could You Give Me the Blue Brick? LEGO<sup>®</sup>-Based Therapy as a Social Development Program for Children with Autism Spectrum Disorder: A Systematic Review.A Multisite Randomized Controlled Two-Phase Trial of the Early Start Denver Model Compared to Treatment as Usual.
Find a Location
Who is running the clinical trial?
University of RochesterOTHER
871 Previous Clinical Trials
549,554 Total Patients Enrolled
11 Trials studying Autism Spectrum Disorder
9,325 Patients Enrolled for Autism Spectrum Disorder
Drexel UniversityOTHER
155 Previous Clinical Trials
47,958 Total Patients Enrolled
9 Trials studying Autism Spectrum Disorder
20,875 Patients Enrolled for Autism Spectrum Disorder
Health Resources and Services Administration (HRSA)Lead Sponsor
85 Previous Clinical Trials
151,389 Total Patients Enrolled
11 Trials studying Autism Spectrum Disorder
1,984 Patients Enrolled for Autism Spectrum Disorder
University of California, DavisOTHER
945 Previous Clinical Trials
4,755,876 Total Patients Enrolled
14 Trials studying Autism Spectrum Disorder
5,637 Patients Enrolled for Autism Spectrum Disorder
University of KansasOTHER
153 Previous Clinical Trials
331,477 Total Patients Enrolled
6 Trials studying Autism Spectrum Disorder
1,008 Patients Enrolled for Autism Spectrum Disorder
University of WashingtonOTHER
1,824 Previous Clinical Trials
1,913,091 Total Patients Enrolled
17 Trials studying Autism Spectrum Disorder
3,985 Patients Enrolled for Autism Spectrum Disorder
University of PennsylvaniaOTHER
2,082 Previous Clinical Trials
42,726,448 Total Patients Enrolled
15 Trials studying Autism Spectrum Disorder
4,303 Patients Enrolled for Autism Spectrum Disorder
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My child is either under 5 years old or over 12.I work at an elementary school, possibly as a teacher, aide, or playground staff.My child, aged 5-12, has ASD or NDD and we are under-resourced.I work at an elementary school, possibly as a teacher, aide, or playground staff.You are attending a Title I school or a rural school.My child, aged 5-12, has ASD or NDD and we are under-resourced.My parent or caregiver is not willing to participate.
Research Study Groups:
This trial has the following groups:- Group 1: Implementation as Usual (IAU)
- Group 2: UNITED
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Autism Spectrum Disorder Patient Testimony for trial: Trial Name: NCT04972838 — N/A